GI Bleeding Flashcards
GI bleeding 2 types
- Overt (visible bleeding)
- Occult (no exteriorization of blood, but person is slowly becoming anemic)
Epidemiology: 4 most common types/causes of GI bleeding
- Upper GI bleeding (60.6)
- Lower GI bleeding (35.7)
- Peptic ulcer bleeding (32.1)
- Colonic diverticular bleeding (23.9)
3 types of overt GI bleeding
Upper
Obscure (middle - most rare)
Lower
Know how to define these in terms of GI regions!
Upper GI bleeding - symptoms
- Hematemesis (vomiting of blood or coffee-ground material)
- Melena (black, tarry stool)
- Hypovolemic shock (+/-)
3 main causes of severe upper GI bleeding
- gastric or duodenal ulcer
- gastric or esophageal varices (rupture)
- erosive esophagitis (due to reflux, drugs, toxins)
Upper GI bleeding: Initial Management
- ABCs (IV, intubation, INR correction)
- Type and cross-match (figure out what blood type the patient has and make sure transfusion blood is ready if needed)
- Fluid resuscitation
- Risk stratification (clinical or endoscopic)
How can the nitrogen and creatinine level help us diagnose upper GI bleeding
?
Patients with upper GI bleeding should undergo … within 12-24 hours.
endoscopic evaluation
Why is endoscopic evaluation so important for patients with upper GI bleeding
It identifies the site of bleeding with a sensitivity of 92% and a specificity near 100% while also providing hemostasis, if needed.
What is the goal of endoscopic therapy for UGIB? (2)
To stop acute bleeding and reduce the risk of recurrent bleeding.
Endoscopic therapy (UGIB) is reserved for…
lesions that have a high risk stigmata
What are some of the available endoscopic treatments (4)
Injection
Thermal coagulation
Mechanical compression (clips)
Hemostatic powders
Briefly understand how these work
Describe the medical therapy for (non-variceal) UGIB (i.e. medications)
Proton Pump Inhibitors:
- Result in profound acid suppression
- Promote platelet aggregation
- Promote and stabilize clot formation
Why are PPIs such a good therapy for UGIB?
They reduce re-bleeding and surgery rates; in patients with high-risk stigmata post endoscopic therapy reduce mortality.
For patients with high risk - dose
High-dose IV PPI over 72 hours